Sort
23,748 grants matching “melanoma”
IMCPL / Flow Cytometry
$213,040Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
A New Radiotracer for Prostate Sentinel Node Mapping
$213,028Anne M Wallace · University Of California, San Diego · R21 · FY2007 · CA
Brain Metastasis Microenvironment and Mechanisms
$213,028Joan Massague · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA
NM23 PROTEINS AND MECHANISMS OF PDGF A CHAIN SILENCING
$213,018University Of Kentucky · R01 · FY2002 · CA
Novel Strategy to Augmenting Immunotherapy against Melanoma
$212,993Jin-Ming Yang · University Of Kentucky · R21 · FY2025 · CA
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER
$212,908University Of Alabama At Birmingham · R01 · FY2003 · CA
OFFICE OF CLINICAL RESEARCH
$212,753James M Pipas · Dartmouth College · P30 · FY2010 · CA
Multi-strain, live biotherapeutics as adjuncts to checkpoint inhibitor therapy
$212,696Hyungsoo Kim · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2022 · CA
Identification of Resistance-Conferring Stromal Alterations in BRAF Mutant Melano
$212,693Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2020 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2018 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2021 · CA
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer
$212,669Randy F. Sweis · University Of Chicago · K08 · FY2019 · CA
Immunogenomics platform for the analysis of cancer
$212,567Vladimir Makarov · Cleveland Clinic Lerner Com-Cwru · R50 · FY2024 · CA
Immunogenomics platform for the analysis of cancer
$212,567Vladimir Makarov · Cleveland Clinic Lerner Com-Cwru · R50 · FY2025 · CA
Administrative Core
$212,538John H Sampson · Duke University · P50 · FY2015 · CA
Raf Kinase Inhibitory Protein (RKIP): A New Hepatocellular Carcinoma Tumor Suppre
$212,520John M. Sedivy · Brown University · R21 · FY2010 · CA
Telomere homolog oligonucleotides for cancer therapy
$212,520Semaco, Inc. · R41 · FY2004 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$212,499Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2000 · CA
Ultrasensitive FACTT assays for serum biomarkers
$212,482Xiaowei Xu · University Of Pennsylvania · R21 · FY2008 · CA
Imaging Core
$212,425Simon C Watkins · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS
$212,396City Of Hope/Beckman Research Institute · U10 · FY2002 · CA
Cancer Center Isolation Facility Shared Resource
$212,379Michael Barry Kastan · Duke University · P30 · FY2015 · CA
PEG-Prom Mediated Theranostics for Prostate Cancer
$212,222Martin G Pomper · Johns Hopkins University · P50 · FY2020 · CA
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY
$212,186Paul B Robbins · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA